CEFAZOLIN Drug Patent Profile
✉ Email this page to a colleague
When do Cefazolin patents expire, and what generic alternatives are available?
Cefazolin is a drug marketed by B Braun, Baxter Hlthcare Corp, Abraxis Pharm, Acs Dobfar, Aurobindo Pharma, Bedford, Cephazone Pharma, Dr Reddys, Facta Farma, Fresenius Kabi Usa, Glaxosmithkline, Hikma, Hikma Farmaceutica, Hospira, Hospira Inc, Qilu Antibiotics, Samson Medcl, Sandoz, Steri Pharma, Teva Pharms, and Hq Spclt Pharma. and is included in thirty-six NDAs.
The generic ingredient in CEFAZOLIN is cefazolin sodium. There are twenty-seven drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the cefazolin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefazolin
A generic version of CEFAZOLIN was approved as cefazolin sodium by SANDOZ on December 9th, 1988.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CEFAZOLIN?
- What are the global sales for CEFAZOLIN?
- What is Average Wholesale Price for CEFAZOLIN?
Summary for CEFAZOLIN
| US Patents: | 0 |
| Applicants: | 21 |
| NDAs: | 36 |
| Drug Prices: | Drug price information for CEFAZOLIN |
| What excipients (inactive ingredients) are in CEFAZOLIN? | CEFAZOLIN excipients list |
| DailyMed Link: | CEFAZOLIN at DailyMed |
US Patents and Regulatory Information for CEFAZOLIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Pharms | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 063016-002 | Mar 14, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Glaxosmithkline | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 064033-001 | Oct 31, 1993 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Dr Reddys | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 062988-002 | Dec 29, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma Farmaceutica | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 065143-001 | Oct 18, 2004 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Samson Medcl | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 065141-001 | Nov 29, 2006 | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hikma | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 062807-006 | Jan 12, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
